[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@doepke_michel Michel Doepke

Michel Doepke posts on X about $ptgx, $jnj, $idya, $crnx the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

X Week XXXXXX -XX%
X Month XXXXXXX -XX%
X Months XXXXXXXXX +68%
X Year XXXXXXXXX +144%

Mentions: XX #

X Week XXX -XX%
X Month XXX -XX%
X Months XXXXX +45%
X Year XXXXX +152%

Followers: XXXXX #

X Week XXXXX +0.70%
X Month XXXXX +3.10%
X Months XXXXX +26%
X Year XXXXX +50%

CreatorRank: XXXXXXX #

Social Influence

Social category influence stocks XXXXX% cryptocurrencies XXXX% finance XXXX% countries XXX% currencies XXX% travel destinations XXX%

Social topic influence $ptgx #6, $jnj #22, $idya #13, $crnx #6, $sny #5, $bayn #2, $nvs #9, $tak #2, market cap #651, $regn #7

Top accounts mentioned or mentioned by @aggregategains @biohazard3737 @bionavgator @midwit_capital @wallstsai @damiangarde @semodough @amaymd @persimmonti @protagonisttxs @reddit @aktionaer @biopharmiq @valuedig @macrovet888 @biotechvantage @maximizebelief2 @mugsley @meadowcapital @sanityninsanity

Top Social Posts

Top posts by engagements in the last XX hours

"$RLMD should receive more attention here. Small position. $ENGN $CGON"
X Link 2025-11-11T14:58Z 5924 followers, 7674 engagements

"$ONC Positive Phase X Results Support ZIIHERA as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma $JAZZ $ZYME"
X Link 2025-11-17T11:03Z 5924 followers, 3305 engagements

"$ARWR the US approval of REDEMPLO is just the beginning. XX clinical stage programs (10 wholly-owned; X partnered) - more to come. Strong comeback: share price has quadrupled from its low for the year. $NVS $SRPT $AMGN $GSK $TAK"
X Link 2025-11-19T08:52Z 5923 followers, 5799 engagements

"$RNA Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44. $NVS $SRPT"
X Link 2025-11-19T14:18Z 5924 followers, 2654 engagements

"$GEHC to acquire Intelerad advancing cloud-enabled enterprise imaging across care settings for $2.3B. #Sectra $SECTRA"
X Link 2025-11-21T07:56Z 5923 followers, 1234 engagements

"$ABVX $RVMD $PTGX trading like a buyout announcement is imminent. Incredible strength"
X Link 2025-11-26T10:38Z 5923 followers, 7577 engagements

"$AZN #Astrazeneca Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension. PDUFA date is anticipated during the second quarter of 2026 following use of a Priority Review voucher. $MLYS"
X Link 2025-12-02T08:09Z 5924 followers, 1486 engagements

"$IDYA great lead asset and more to come. Still too cheap imho. #ESMO25"
X Link 2025-10-18T21:43Z 5924 followers, 3442 engagements

"$IDYA Announces Positive Phase X Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma in a Proffered Paper Oral Presentation at ESMO 2025"
X Link 2025-10-20T10:32Z 5923 followers, 1167 engagements

"$SMMT $500M PIPE @ $18.74$ per share. $AZN Summit Co-CEO and Executive Chairman Robert Duggan Co-CEO and President Mahkam Zanganeh CFO and COO Manmeet Soni CAO Bhaskar Anand and certain non-executive employees invested $272M; Akeso invested $10M remaining $218M raised with multiple leading biopharma institutional investors and other institutional investors"
X Link 2025-10-22T12:24Z 5924 followers, 9023 engagements

"$LLY to acquire $ADVM - $XXXX per share + $XXXX per CVR"
X Link 2025-10-24T12:33Z 5924 followers, 6144 engagements

"$IDYA 52-week high"
X Link 2025-10-28T13:43Z 5923 followers, 4487 engagements

"$NBIX Reports Third Quarter 2025 Financial Results. CRENESSITY (crinecerfont) Third-Quarter 2025 Net Product Sales of $98M"
X Link 2025-10-28T20:10Z 5924 followers, 1209 engagements

"$IDYA despite 52-week high just $2.9B market cap. $992M cash at the end of June + $210M upfront payment from Servier. Financed over several years. Multiple shots on goal - I wouldn't be surprised if $IDYA trades above $XXX in the long term"
X Link 2025-10-29T10:25Z 5923 followers, 2480 engagements

"$PTGX strong finish yesterday into close. The company knows how valuable the asset Icotrokinra is and what potential the early stage programs have. Protagonist will not and does not want to sell itself below value. I think that patience will pay off here. $JNJ $TAK"
X Link 2025-10-29T11:47Z 5923 followers, 2827 engagements

"$SMMT Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer"
X Link 2025-11-03T06:21Z 5923 followers, 1974 engagements

"$IDYA Reports Third Quarter 2025 Financial Results and Provides Business Update. $1.14B cash"
X Link 2025-11-04T11:05Z 5923 followers, XXX engagements

"#Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse. Transaction includes $350M in cash and upfront license fees. JEB partnered projects below. $SDZ $EVT"
X Link 2025-11-05T07:00Z 5923 followers, 1133 engagements

"$ONC Q3 results. Third quarter total revenues increased XX% to $1.4B"
X Link 2025-11-06T11:03Z 5925 followers, 1062 engagements

"$VRTX $ALPN Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at ASN Kidney Week. $NVS #Otsuka"
X Link 2025-11-09T10:55Z 5924 followers, 5624 engagements

"An approval for Povetacicept (formerly ALPN-303) would also be a success for German based #Evotec. They have a multi-year partnership with $ALPN which was acquired by $VRTX for $4.9B in 2024"
X Link 2025-11-09T11:45Z 5924 followers, 3971 engagements

"$IFRX Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU). $UCB $MLTX $CLDX"
X Link 2025-11-10T12:32Z 5924 followers, 1555 engagements

"The year of liver diseases $ETNB and $AKRO gone. $MDGL new ATH $12B valuation. 😎👍"
X Link 2025-11-11T16:12Z 5922 followers, 5248 engagements

"$EVT #Evotecreceives milestone payment from $BMY Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership. $5M to Evotec"
X Link 2025-11-12T06:43Z 5922 followers, 1254 engagements

"$LEGN Q3 results. Carvykti net trade sales of approximately $524M. $JNJ"
X Link 2025-11-12T12:04Z 5922 followers, XXX engagements

"$AXSM new ATH - interesting potential buyout target. $BPMC $ITCI $VRNA and $SWTX gone (see list below)"
X Link 2025-11-12T15:32Z 5924 followers, 3886 engagements

"Long $CRNX and $PTGX 👍"
X Link 2025-11-13T14:29Z 5922 followers, 2982 engagements

"Next bidding war M&A in the biotech space is heating up $AVDL Board of Directors Determines Proposal From #Lundbeck Reasonably Expected to Result in a Company Superior Proposal. $ALKS"
X Link 2025-11-14T10:53Z 5924 followers, 8225 engagements

"$AVDL Board of Directors Declares Lundbeck Proposal a Company Superior Proposal. . $ALKS"
X Link 2025-11-17T10:55Z 5924 followers, 1265 engagements

"$MRUS and $HALO Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab"
X Link 2025-11-17T12:40Z 5925 followers, 1686 engagements

"$VSTM $MCRB"
X Link 2025-11-17T20:31Z 5924 followers, 1687 engagements

"$CELC Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer"
X Link 2025-11-17T21:07Z 5922 followers, 1504 engagements

"$PTGX $JNJ $TAK"
X Link 2025-11-18T12:56Z 5922 followers, 3700 engagements

"$ALKS Announces Increased Offer to Acquire $AVDL - for total transaction consideration of up to $XXXXX per share #BiddingWar #Lundbeck"
X Link 2025-11-19T11:01Z 5924 followers, 1461 engagements

"What would $PTGX be worth if Icotrokinra and Rusfertide weren't partnered In my opinion $PTGX could be in the range of $INSM in terms of market cap in some years. Large markets ingenious technology (oral). What pharma wants - easily available"
X Link 2025-11-20T14:01Z 5922 followers, 8599 engagements

"$REGN $SNY Dupixent (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU). $CLDX"
X Link 2025-11-25T06:46Z 5925 followers, 12.2K engagements

"From injections to pills: oral peptides set to transform drug development (August 2025). $PTGX $JNJ $MRK"
X Link 2025-11-27T09:33Z 5922 followers, 4057 engagements

"$PTGX TD Cowen Advancements in #Obesity Summit. Some interesting comments. $LLY $NVO"
X Link 2025-11-27T15:01Z 5922 followers, 3323 engagements

"#Eisai Submits New Drug Application for Subcutaneous Formulation of Leqembi for the Treatment of Early Alzheimers Disease in Japan. $BIIB $BIOA.ST"
X Link 2025-11-28T07:08Z 5924 followers, 1862 engagements

"$KYMR data in December. Barclays comment below. $NKTR $REGN $SNY $CRVS"
X Link 2025-12-01T06:53Z 5924 followers, 4925 engagements

"$IDYA Announces IND Clearance for IDE034 a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types"
X Link 2025-12-01T11:41Z 5922 followers, 2305 engagements

"$VTYX Provides Clinical and Corporate Updates"
X Link 2025-12-02T12:03Z 5924 followers, 1538 engagements

"$SGMO Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy"
X Link 2025-12-02T13:11Z 5923 followers, 2260 engagements

"$BAYN #Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia"
X Link 2025-12-02T13:44Z 5925 followers, XXX engagements

"$CLDX strength up X% after $JSPR asthma data"
X Link 2025-12-02T17:09Z 5924 followers, 2193 engagements

"$CAPR Announces Positive Topline Results from Pivotal Phase X HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy. $SRPT"
X Link 2025-12-03T12:36Z 5924 followers, 2661 engagements

"$CRNX next step 👍"
X Link 2025-12-03T13:11Z 5924 followers, 2281 engagements

"What else can $ABBV say Rinvoq and Skyrizi are THE growth drivers in the portfolio following the Humira patent cliff. Competition is not welcome here - I can imagine that AbbVie will purchase/license further assets in this area and in the field of obesity. $ABVX $GUBRA"
X Link 2025-12-04T14:48Z 5925 followers, 2882 engagements

"IDE034 a Bispecific #ADC Licensed by Biocytogen to $IDYA Receives FDA IND Clearance"
X Link 2025-12-05T07:09Z 5923 followers, 1203 engagements

"$NTRA Acquires #Foresight Diagnostics - all-stock transaction consisting of a $XXX million upfront with an additional $XXX million in earnouts tied to the achievement of revenue- and reimbursement-based milestones"
X Link 2025-12-05T12:08Z 5923 followers, 1706 engagements

"$CLDX 52-week high yesterday. The bulls are finally waking up. 2026 will be an extremely important year for Celldex. Small position"
X Link 2025-12-05T12:38Z 5924 followers, XXX engagements

"$BPMC a $SNY Company Highlights Long-Term Clinical Benefit of AYVAKIT (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting. $COGT"
X Link 2025-12-05T13:06Z 5923 followers, 4390 engagements

"The "robots are on the move" see $IRBT. I'm wondering why $BB hasn't jumped yet. But it could still happen. Current share price: $XXXX #QNX #Robotics @Reddit"
X Link 2025-12-05T13:45Z 5924 followers, 1878 engagements

"$PTGX strength into the weekend. Deal close $JNJ $TAK"
X Link 2025-12-05T20:00Z 5922 followers, 2875 engagements

"$GSK GSK terminates collaboration agreement with $IDYA"
X Link 2025-12-06T06:56Z 5922 followers, 8536 engagements

"$GMAB Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)"
X Link 2025-12-06T17:57Z 5924 followers, 2379 engagements

"$ZLAB Announces Updates to Chinas National Reimbursement Drug List"
X Link 2025-12-07T09:57Z 5923 followers, 1555 engagements

"OSE Immunotherapeutics Announces Strategic Amendment to AbbVies Partnership on ABBV-230 Development. $ABBV"
X Link 2025-12-08T06:35Z 5922 followers, 1403 engagements

"$KYTX nnounces Positive Interim Phase X Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 2025. $ARGX $JNJ"
X Link 2025-10-29T10:33Z 5925 followers, 1059 engagements

"$RYTM Announces Public Reimbursement for IMCIVREE (setmelanotide) in Canada in Five Provinces and Under the Federal Non-Insured Health Benefits Program"
X Link 2025-11-05T21:03Z 5925 followers, XXX engagements

"$CAI Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance"
X Link 2025-11-05T21:06Z 5925 followers, 1258 engagements

"$BAYN #Bayer significant gains for Nubeqa and Kerendia but business headwinds mainly related to declines for Xarelto due to patent expirations as well as lower Eylea sales. #Orion $REGN"
X Link 2025-11-12T06:48Z 5925 followers, 1701 engagements

"$BAYN #Bayer The glyphosate case is and remains a never-ending story at Bayer. Provisions for legal costs are being increased again. Compared to the previous year there are now 2000 more lawsuits pending. $MON"
X Link 2025-11-12T06:54Z 5925 followers, 1688 engagements

"$BAYN #Bayer FDA grants accelerated approval to Bayers HYRNUO (sevabertinib) for patients with previously treated advanced HER2-mutant non-small cell lung cancer"
X Link 2025-11-20T07:36Z 5925 followers, 1600 engagements

"$BAYN #Bayer Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention. $BMY $JNJ"
X Link 2025-11-23T17:33Z 5925 followers, 2936 engagements

"Exclusive: I met Jennifer Ruddock CBO of $NKTR at BIO Europe in Vienna. Read the interview (Part 1) 👇 $LLY"
X Link 2025-11-30T09:16Z 5925 followers, 9553 engagements

"$BAYN #Bayer welcomes Solicitor General support for U.S. Supreme Court review. Shares up 9%"
X Link 2025-12-02T06:49Z 5925 followers, 1383 engagements

"Interesting. $ABBV already partnered with $GUBRA (amylin) this year. Who's next $LLY $NVO $VKTX $GPCR"
X Link 2025-12-03T16:44Z 5925 followers, 7136 engagements

"Influential study on #glyphosate safety retracted XX years after publication - "several critical issues that are considered to undermine the academic integrity of this article and its conclusions." $MON $BAYN #Bayer #Glyphosat"
X Link 2025-12-04T07:47Z 5925 followers, 1007 engagements

"$PODD Announces FDA 510(k) Clearance of Omnipod X Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience. $TNDM"
X Link 2025-12-04T12:01Z 5925 followers, 1025 engagements

"$DNLI and $RPRX Announce $XXX Million Royalty Funding Agreement"
X Link 2025-12-04T12:02Z 5925 followers, 4452 engagements

"$GLPG Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025"
X Link 2025-12-08T06:35Z 5925 followers, XXX engagements

"Wow: LORAL GROUPE TO REINFORCE ITS STRATEGIC INVESTMENT IN #GALDERMA WITH AN ADDITIONAL XX% BRINGING ITS TOTAL PARTICIPATION TO 20%"
X Link 2025-12-08T06:36Z 5925 followers, 3159 engagements

"$CRNX looking good"
X Link 2025-11-17T17:03Z 5926 followers, 1323 engagements

"$CRNX Announces First Patient Randomized in Pivotal Phase X CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome"
X Link 2025-11-21T06:59Z 5926 followers, 1313 engagements

"After $JNJ and $NVO failures: $BMY Announces Continuation of ADEPT-2 Phase X Study in Psychosis Associated with Alzheimer's Disease"
X Link 2025-12-03T12:08Z 5927 followers, 4235 engagements

"$CRNX break. Next target $60"
X Link 2025-12-03T15:22Z 5926 followers, 1981 engagements

"$HALO Wins Preliminary Injunction Against Merck's Keytruda SC in Germany. $MRK"
X Link 2025-12-04T18:33Z 5927 followers, 2424 engagements

"$PTGX and $TAK Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera"
X Link 2025-12-06T17:56Z 5926 followers, 1482 engagements

"$COGT Presents Full SUMMIT Results ofBezuclastinibinPatientswithNonAdvancedSystemic Mastocytosis (NonAdvSM)at the67thAnnual Meeting of the American Society of Hematology (ASH) $BPMC $SNY"
X Link 2025-12-06T18:00Z 5927 followers, 8617 engagements

"$UCB presents positive results from GEMZ phase X study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder"
X Link 2025-12-08T06:37Z 5926 followers, 1646 engagements

"$GPCR $WVE $KYMR and $DYN data ahead - busy #biotech Monday. Maybe also a M&A deal $PTGX $RVMD $ABVX"
X Link 2025-12-08T07:52Z 5927 followers, 7951 engagements

"$PTGX early stage program but PN-881 could have gamechanger potential. It's incredible how strongly $UCB is growing with Bimzelx. A multi-billion dollar opportunity - and $JNJ may be aware of this potential. Maybe we get a PR tomorrow - $JNJ to report Q3 results on Tuesday. $NVS"
X Link 2025-10-12T18:25Z 5928 followers, 7180 engagements

"$TAK Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors"
X Link 2025-10-22T05:10Z 5928 followers, 1963 engagements

"$PTGX PN-881 entered the clinical stage. First human subject dosed in a Phase X trial in October"
X Link 2025-11-07T10:07Z 5928 followers, 3341 engagements

"$CRNX pipeline. $1.1B Cash Balance Funds Current Operating Plan into 2029. Market cap: $4B. The focus is now on the commercial roll-out of Palsonify. $CAMX"
X Link 2025-11-07T10:16Z 5929 followers, 9017 engagements

"$RHHBY fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis. $TGTX"
X Link 2025-11-10T06:02Z 5928 followers, 4884 engagements

"$COGT Reports Positive Results from Bezuclastinib PEAK Phase X Trial in Gastrointestinal Stromal Tumors (GIST). $BPMC $SNY $DCPH"
X Link 2025-11-10T12:01Z 5928 followers, 17.3K engagements

"$DAWN to Acquire $MRSN - $XX per share + CVR"
X Link 2025-11-13T12:59Z 5929 followers, 1170 engagements

"$SGEN ($43B) $ARNA ($7B) $GBT ($5B) $ARRY ($11B) $MTSR ($8B upfront) $TRIL ($2B) $MDVN ($14B) $BHVN ($12B) = $102B. $PFE market cap: $144B"
X Link 2025-11-18T15:25Z 5928 followers, 131.2K engagements

"Exclusive: I met Jennifer Ruddock CBO of $NKTR at BIO Europe in Vienna. Read the interview (Part 2) 👇 $SNY $REGN $AMGN @aktionaer"
X Link 2025-11-30T09:53Z 5928 followers, 4639 engagements

"$CRVS additional data in January Barclays comment below. $NKTR $KYMR $SNY $REGN"
X Link 2025-12-01T06:53Z 5928 followers, 8356 engagements

"$REGN and Tessera Therapeutics to Jointly Develop TSRA-196 an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (#AATD)"
X Link 2025-12-01T12:01Z 5928 followers, 1313 engagements

"Baker Bros are not always right but I consider them to be among the top investors in the biotech scene. Many very successful stocks and M&A candidates with high weighting. 👇 $MDGL $INSM $RYTM $RVMD $CELC $GRAL $ABVX $ARWR"
X Link 2025-12-04T09:38Z 5929 followers, 7604 engagements

"$PCSC Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform. $GRAL $ILMN $EXAS"
X Link 2025-12-05T13:53Z 5928 followers, 2250 engagements

"$GUBRA #BoehringerIngelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development. $LLY $NVO $VKTX $ABBV"
X Link 2025-12-08T07:05Z 5929 followers, 1378 engagements

"Greetings from #DisneylandParis - I hope for a French #biotech buyout soon 😉 Strong day for $ABVX 💪"
X Link 2025-12-09T22:23Z 5929 followers, 3972 engagements

"Good timing past week added @ $XXXX 🔥 $PALI now: $2.18"
X Link 2025-12-10T20:11Z 5929 followers, 2200 engagements

"$ZEAL outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health"
X Link 2025-12-11T07:08Z 5929 followers, XXX engagements